We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Topic: Primary Care Research Network for England Subtopic: Not Assigned Disease: Chronic fatigue syndrome (CFS)/ myalgic encephalomyelitis (ME)
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Not provided at time of registration
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32426159/ results (added 26/05/2020)
You can take part if:
You may not be able to take part if:
Patients where fatigue is due to another cause. This means that GPs will not refer patients with an active illness such as cancer, liver cirrhosis etc.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Ms
Sarah
Horne
+44 (0)117 4145792
Sarah.Horne@nbt.nhs.uk
The study is sponsored by North Bristol NHS Trust (UK) and funded by National Institute for Health Research (Grant Codes: PB-PG-1010-23253).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 11924
You can print or share the study information with your GP/healthcare provider or contact the research team directly.